IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nwuba, R. I.
Right arrow Articles by Nwagwu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nwuba, R. I.
Right arrow Articles by Nwagwu, M.

 Previous Article  |  Next Article 

Infection and Immunity, September 2002, p. 5328-5331, Vol. 70, No. 9
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.9.5328-5331.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Human Immune Response to Plasmodium falciparum Includes Both Antibodies That Inhibit Merozoite Surface Protein 1 Secondary Processing and Blocking Antibodies

Roseangela I. Nwuba,1 Olugbemiro Sodeinde,2 Chiaka I. Anumudu,1 Yusuf O. Omosun,1 Alexander B. Odaibo,1 Anthony A. Holder,3* and Mark Nwagwu1

Cellular Parasitology Programme, Department of Zoology,1 Department of Paediatrics, University College Hospital, University of Ibadan, Ibadan, Nigeria,2 Division of Parasitology, National Institute for Medical Research, London NW7 1AA, United Kingdom3

Received 21 December 2001/ Returned for modification 12 March 2002/ Accepted 29 May 2002

Malaria merozoite surface protein 1 (MSP1) is cleaved in an essential step during erythrocyte invasion. The responses of children to natural malaria infection included antibodies that inhibit this cleavage and others that block the binding of these inhibitory antibodies. There was no correlation between the titer of the antibody to the 19-kDa fragment of MSP1 and its inhibitory activity. These findings have implications for the design of MSP1-based vaccines.


* Corresponding author. Mailing address: Division of Parasitology, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, United Kingdom. Phone: (44) 208-959-3666, ext. 2175. Fax: (44) 208-913-8593. E-mail: aholder{at}nimr.mrc.ac.uk.

Editor: J. M. Mansfield


Infection and Immunity, September 2002, p. 5328-5331, Vol. 70, No. 9
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.9.5328-5331.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.